MicroRNA panel provides a more precise lung cancer diagnosis
Wednesday, September 29, 2010 - 15:56
in Health & Medicine
A test based on a panel of microRNAs under development by Rosetta Genomics, Ltd., in Rehovot, Israel, may allow for more precise diagnosis and better targeted therapy for patients with lung cancer.